US Stock MarketDetailed Quotes

Aptevo Therapeutics (APVO)

Watchlist
  • 4.760
  • -0.130-2.66%
Close Jun 9 15:59 ET
  • 4.740
  • -0.020-0.42%
Post 20:01 ET
5.93MMarket Cap-0.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aptevo Therapeutics (APVO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.51%6.84M
6.95%26.31M
-6.05%6M
45.98%7.61M
3.35%6.23M
-7.20%6.48M
-14.81%24.6M
-0.03%6.38M
-20.55%5.21M
-26.34%6.02M
Selling and administrative expenses
2.32%2.91M
15.14%11.77M
-1.64%2.46M
69.00%3.57M
21.71%2.9M
-11.88%2.85M
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
-General and administrative expense
2.32%2.91M
15.14%11.77M
-1.64%2.46M
69.00%3.57M
21.71%2.9M
-11.88%2.85M
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
Research and development costs
8.01%3.92M
1.13%14.54M
-8.89%3.54M
30.33%4.04M
-8.65%3.33M
-3.17%3.63M
-15.95%14.38M
8.05%3.88M
-20.17%3.1M
-33.30%3.64M
Operating profit
-5.51%-6.84M
-6.95%-26.31M
6.05%-6M
-45.98%-7.61M
-3.35%-6.23M
7.20%-6.48M
14.81%-24.6M
0.03%-6.38M
20.55%-5.21M
26.34%-6.02M
Net non-operating interest income expense
Other net income (expense)
94.44%140K
-26.91%345K
171.43%190K
-45.54%61K
-84.40%22K
-51.68%72K
-95.39%472K
-62.77%70K
-50.66%112K
-38.70%141K
Special income (charges)
----
----
----
----
----
----
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
--0
--0
--0
--0
Other non- operating income (expenses)
94.44%140K
-26.91%345K
171.43%190K
-45.54%61K
-84.40%22K
-51.68%72K
-18.34%472K
-62.77%70K
-50.66%112K
-38.70%141K
Income before tax
-4.51%-6.7M
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
Income tax
Net income
-4.51%-6.7M
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
Net income continuous Operations
-4.51%-6.7M
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
Net income discontinuous operations
----
----
----
----
----
----
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-4.51%-6.7M
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
Preferred stock dividends
Other preferred stock dividends
97K
1.57M
92K
1.48M
0
0
0
0
Net income attributable to common stockholders
-6.02%-6.79M
-14.12%-27.54M
6.56%-5.9M
-76.98%-9.03M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
Basic earnings per share
99.59%-6.41
98.53%-87.27
99.62%-5.9108
98.99%-40.14
99.21%-151.2
98.84%-1.58K
98.87%-5.96K
99.13%-1.56K
98.49%-3.99K
97.10%-19.23K
Diluted earnings per share
99.59%-6.41
99.72%-87.27
99.62%-5.9108
98.99%-40.14
99.32%-151.2
98.84%-1.58K
94.04%-31.46K
99.13%-1.56K
98.49%-3.99K
96.64%-22.27K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.51%6.84M6.95%26.31M-6.05%6M45.98%7.61M3.35%6.23M-7.20%6.48M-14.81%24.6M-0.03%6.38M-20.55%5.21M-26.34%6.02M
Selling and administrative expenses 2.32%2.91M15.14%11.77M-1.64%2.46M69.00%3.57M21.71%2.9M-11.88%2.85M-13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M
-General and administrative expense 2.32%2.91M15.14%11.77M-1.64%2.46M69.00%3.57M21.71%2.9M-11.88%2.85M-13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M
Research and development costs 8.01%3.92M1.13%14.54M-8.89%3.54M30.33%4.04M-8.65%3.33M-3.17%3.63M-15.95%14.38M8.05%3.88M-20.17%3.1M-33.30%3.64M
Operating profit -5.51%-6.84M-6.95%-26.31M6.05%-6M-45.98%-7.61M-3.35%-6.23M7.20%-6.48M14.81%-24.6M0.03%-6.38M20.55%-5.21M26.34%-6.02M
Net non-operating interest income expense
Other net income (expense) 94.44%140K-26.91%345K171.43%190K-45.54%61K-84.40%22K-51.68%72K-95.39%472K-62.77%70K-50.66%112K-38.70%141K
Special income (charges) --------------------------0--0--0--0
-Gain on sale of property,plant,equipment --------------------------0--0--0--0
Other non- operating income (expenses) 94.44%140K-26.91%345K171.43%190K-45.54%61K-84.40%22K-51.68%72K-18.34%472K-62.77%70K-50.66%112K-38.70%141K
Income before tax -4.51%-6.7M-7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M
Income tax
Net income -4.51%-6.7M-7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M
Net income continuous Operations -4.51%-6.7M-7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M
Net income discontinuous operations --------------------------0--0--0--0
Minority interest income
Net income attributable to the parent company -4.51%-6.7M-7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M
Preferred stock dividends
Other preferred stock dividends 97K1.57M92K1.48M0000
Net income attributable to common stockholders -6.02%-6.79M-14.12%-27.54M6.56%-5.9M-76.98%-9.03M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M
Basic earnings per share 99.59%-6.4198.53%-87.2799.62%-5.910898.99%-40.1499.21%-151.298.84%-1.58K98.87%-5.96K99.13%-1.56K98.49%-3.99K97.10%-19.23K
Diluted earnings per share 99.59%-6.4199.72%-87.2799.62%-5.910898.99%-40.1499.32%-151.298.84%-1.58K94.04%-31.46K99.13%-1.56K98.49%-3.99K96.64%-22.27K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.11%
Sample Name
Sample Code
 -0.21%
Sample Name
Sample Code
 -1.11%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.19%
5
VanEck Oil Services ETF
OIH
-2.41%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 -1.40%
Sample Name
Sample Code
 -1.54%
Sample Name
Sample Code
 -1.86%
4
MINISO
MNSO
-2.08%
5
GDS Holdings
GDS
-2.17%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East are escalating: Iran shot down a U.S. Apache helicopter, prompting retaliatory U.S. airstrikes on multiple locat Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -